Sort
48,018 grants matching “immunotherapy”
Mycobacterial antigen compartmentalization &immunity
$359,003University Of Wisconsin Madison · R01 · FY2004 · AI
Designer T Cell Therapy for PML
$359,000Roger Williams Hospital · R01 · FY2004 · AI
Peptide Vaccination Targeting Tumor-Specific IDH1R132H Mutation for Brain Tumors
$358,971John H Sampson · Duke University · P50 · FY2018 · CA
Tailoring AAV Vectors for Glioma Immunotherapy
$358,962Ou Cao · University Of Florida · R01 · FY2011 · AI
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
$358,900Jun Yan · University Of Louisville · R01 · FY2011 · CA
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
$358,900Jun Yan · University Of Louisville · R01 · FY2012 · CA
Engineer Biomimetic Microfluidic Models to Investigate and Reprogram Tumor Associated Neutrophils for Cancer Therapy
$358,885Xiaoping Bao · Purdue University · R37 · FY2022 · CA
Mycobacterial antigen compartmentalization &immunity
$358,860University Of Wisconsin Madison · R01 · FY2005 · AI
Targeting Wnt signaling in therapy-resistant ovarian cancer
$358,851Benjamin G Bitler · University Of Colorado Denver · R37 · FY2025 · CA
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
$358,834Jean Zhao · Brigham And Women'S Hospital · P50 · FY2020 · CA
Immunotherapy against tauopathy in a transgenic mouse model
$358,823David Morgan · University Of South Florida · R01 · FY2015 · NS
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
$358,773Matthias Gromeier · Duke University · R01 · FY2024 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$358,756Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Genetically Engineered Viruses for Prostate Cancer Ther
$358,750Massachusetts General Hospital · R01 · FY2005 · CA
CD8 T-Cells and Host Defense Against P. Carinii
$358,750Children'S Hosp Pittsburgh/Upmc Hlth Sys · R01 · FY2004 · HL
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
$358,748Jerry D Glickson · University Of Pennsylvania · R01 · FY2012 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$358,720Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Identification of Druggable Targets to Complement Melanoma Therapy
$358,700Alan Jackson Tackett · Univ Of Arkansas For Med Scis · R01 · FY2019 · CA
CHILDRENS CANCER GROUP
$358,698Children'S Hospital Los Angeles · U10 · FY2002 · CA
Macrophage-based ovarian cancer immunotherapy
$358,694Fiona E Yull · Vanderbilt University · R01 · FY2020 · CA
Macrophage-based ovarian cancer immunotherapy
$358,683Fiona E Yull · Vanderbilt University · R01 · FY2018 · CA
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
$358,680Goldy C George · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
$358,680Jianjun Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
$358,680Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Development of B-cell-based vaccine for Glioblastoma
$358,680Catalina Lee Chang · Northwestern University At Chicago · R37 · FY2023 · CA